Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estramustine inhibits monocyte phagocytosis.

L Bjermer1, E von Schoultz, B Norberg

  • 1Department of Oncology, University of Umeå, Sweden.

The Prostate
|January 1, 1988
PubMed
Summary

Estramustine phosphate (EMP) significantly impairs human monocyte phagocytosis of yeast cells in vitro. This immune cell function inhibition, observed at clinical concentrations, suggests potential pathophysiological implications for cancer patients undergoing treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Update on Non-Biological and RNA-Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper.

Allergy·2026
Same author

Shaping the Future of Respiratory Care: A Look Into the Next Decade and Strategic Recommendations by the European Forum for Research and Education in Allergy and Airways Diseases.

Chest·2026
Same author

Pocket guide: biologics in upper and lower airways in adults.

Rhinology·2025
Same author

EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP.

Rhinology·2024
Same author

Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology.

Allergy·2023
Same author

EUFOREA summit in Brussels 2023: <i>inspiring the future of allergy & respiratory care</i>.

Frontiers in allergy·2023

Area of Science:

  • Immunology
  • Pharmacology
  • Cell Biology

Background:

  • Estramustine phosphate (EMP) is utilized in advanced prostatic carcinoma treatment.
  • Understanding EMP's impact on immune cell function is crucial for patient management.
  • Phagocytosis is a key immune process involving engulfment and adherence.

Purpose of the Study:

  • To investigate the in vitro effect of Estramustine phosphate (EMP) on human monocyte phagocytosis.
  • To differentiate the impact of EMP on yeast cell engulfment versus adherence.
  • To assess the role of EMP metabolites in phagocytosis.

Main Methods:

  • Utilized a modified Hed's technique for in vitro phagocytosis assays.
  • Employed fluorescein isothiocyanate (FITC)-labeled yeast cells for monitoring.

Related Experiment Videos

  • Measured human monocyte interaction with yeast cells, distinguishing engulfment and adherence.

    • Main Results:

    • Estramustine phosphate (EMP) at clinical concentrations (20-40 µg/ml) significantly inhibited yeast cell engulfment by monocytes.
    • Cell adherence was less affected compared to the engulfment phase.
    • EMP metabolites, estradiol and normustine, did not impact yeast cell engulfment.

    Conclusions:

    • Estramustine phosphate (EMP) directly impairs the phagocytic engulfment process, potentially via microtubule interaction.
    • The observed inhibition of phagocytosis by EMP may have pathophysiological significance in immunocompromised cancer patients.
    • Effects of EMP on phagocytosis were fully reversible.